Beta brachytherapy of an old degenerated saphenous vein graft with occlusive in-stent restenosis

Ital Heart J. 2003 Sep;4(9):646-50.

Abstract

We report a case of obstructive in-stent restenosis in a diffusely diseased saphenous vein graft complicated by a non-ST-elevation myocardial infarction. With tirofiban infusion, the extensively occluded saphenous bypass was reperfused, establishing a TIMI flow 3, and then entirely irradiated with a beta source (32P) without any complication. At 7 months the patient was asymptomatic and the control angiogram did not reveal any restenosis. In conclusion, 32P beta brachytherapy may be extremely effective not only in case of native vessel in-stent restenosis but also in cases of high-risk vein graft in-stent restenosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary
  • Aspirin / therapeutic use
  • Beta Particles / therapeutic use
  • Blood Vessel Prosthesis
  • Brachytherapy*
  • Coronary Angiography
  • Coronary Artery Bypass
  • Coronary Artery Disease / surgery
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Graft Occlusion, Vascular / etiology*
  • Graft Occlusion, Vascular / radiotherapy*
  • Humans
  • Myocardial Infarction / radiotherapy
  • Myocardial Infarction / therapy
  • Phosphorus Radioisotopes / therapeutic use
  • Reoperation
  • Saphenous Vein / diagnostic imaging
  • Saphenous Vein / radiation effects*
  • Saphenous Vein / transplantation*
  • Stents / adverse effects*
  • Ticlopidine / therapeutic use
  • Tirofiban
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use

Substances

  • Fibrinolytic Agents
  • Phosphorus Radioisotopes
  • Tyrosine
  • Tirofiban
  • Ticlopidine
  • Aspirin